Prestige Consumer Healthcare
PBH
#3906
Rank
NZ$5.30 B
Marketcap
NZ$107.79
Share price
0.17%
Change (1 day)
-22.46%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$7.02

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.97. In 2024 the company made an earnings per share (EPS) of NZ$7.38 an increase over its 2023 EPS that were of NZ-$2.76.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$7.02-4.88%
2024NZ$7.38-367.08%
2023NZ-$2.76-138.33%
2022NZ$7.2111.7%
2021NZ$6.4613.6%
2020NZ$5.68-651.67%
2019NZ-$1.03-148.78%
2018NZ$2.11-83.29%
2017NZ$12.64437.23%
2016NZ$2.35-34.13%
2015NZ$3.5752.94%
2014NZ$2.33-8.11%
2013NZ$2.54
2011NZ$1.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
NZ$6.17-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$2.95-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
NZ-$50.85-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.92 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.09-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$12.64 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
NZ$12.07 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$0.69-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$11.00 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.83 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA